| Full text | |
| Author(s): |
Calado, Rodrigo T.
Total Authors: 1
|
| Document type: | Journal article |
| Source: | SEMINARS IN HEMATOLOGY; v. 60, n. 4, p. 4-pg., 2023-11-14. |
| Abstract | |
Aplastic anemia (AA) is a rare serious hematologic disorder caused by hematopoietic stem cell failure in maintaining hematopoiesis. AA is virtually fatal if not treated, and diagnosis and therapy require exten-sive hematologic infrastructure. Academic medical centers in Brazil have continuously and significantly contributed to diagnostic tools and therapy development, from novel transplant strategies to drug com-binations and implementation science in the national public health system. In the present review, we discuss how the collaborative effort among academic centers in hematology has contributed to improv-ing health care for patients with aplastic anemia. We also discuss what needs are still unmet and how to overcome these challenges.(c) 2023 Elsevier Inc. All rights reserved. (AU) | |
| FAPESP's process: | 13/08135-2 - CTC - Center for Cell-Based Therapy |
| Grantee: | Dimas Tadeu Covas |
| Support Opportunities: | Research Grants - Research, Innovation and Dissemination Centers - RIDC |
| FAPESP's process: | 19/17520-3 - Immune signature in telomeropathies |
| Grantee: | Rodrigo do Tocantins Calado de Saloma Rodrigues |
| Support Opportunities: | Regular Research Grants |